Sunderland Joint Formulary
NHS Sunderland Clinical Commissioning Group
South Tyneside and Sunderland NHS Foundation Trust

6 Endocrine system

06-07 Other endocrine drugs


Inotersen is recommended, within its marketing authorisation, as an option for treating stage 1 and stage 2 polyneuropathy in adults with hereditary transthyretin amyloidosis. It is recommended only if the company provides inotersen according to the commercial arrangement.

Link  NICE Highly specialised technologies guidance [HST9]: Inotersen for treating hereditary transthyretin amyloidosis

Red View adult BNF  View SPC online  HCD
Ketoconazole Ketoconazole HRA
Tablets: 200mg

Indication: Cushing's Syndrome

Red View adult BNF  View SPC online